The RNA binding proteins ZFP36L1 and ZFP36L2 modulate transcriptional and post-transcriptional genome-wide effects of glucocorticoids
Jennifer RynneiD, Elena Ortiz ZapateriD, Paniz Khooshemehri, Nicole O. PondeiD, Giselda BuccaiD, Andrew R. HeskethiD, Manuela PlatéiD, Rachel Clare ChambersiD, Colin P. Sambrook SmithiD, Rocío T. Martínez-NuñeziD
Abstract
Glucocorticoids (GCs) are one of the most used anti-inflammatory drugs worldwide. Despite their widespread use, our understanding of their post-transcriptional effects remains poorly understood. The tristetraprolin (TTP) RNA binding protein (RBP) family (ZFP36, ZFP36L1 and ZFP36L2) has been implicated in inflammation regulation via binding to AU-rich elements (ARE) in mRNAs, with TTP being implicated in GC modulation. We hypothesised that ZFP36L1 and ZFP36L2 are part of the GC pathway and tested this hypothesis in bronchial epithelium, which commonly encounters GC in vivo upon inhalation. Our data show that dexamethasone, a commonly used GC, modulated the levels, subcellular localisation and RNA binding of ZFP36L1/L2. Employing Frac-seq (subcellular fractionation and RNA-sequencing), we show that GC modulated distinct subsets of RNAs in a subcellular-dependent manner. In addition to their mostly known transcriptional effects (116 differentially expressed genes, DEGs), GCs modified the binding to monosomes of myriad mRNAs (83 differentially bound genes, DBGs). We also demonstrate that ZFP36L1/L2 modulated gene expression mainly at the total cytoplasmic and polyribosome binding levels. ZFP36L1/L2 down-regulation led to an increase in ARE-containing mRNAs and a pronounced modification of the effects of GC on gene expression. We observed a small overlap of genes modulated by GCs when comparing control and ZFP36L1/L2 knockdown cells, in a subcellular-dependent manner Our data also suggest a novel role for these RBPs and GCs in epithelial biology via regulation of mRNAs encoding proteins important for epithelial cell function including cellular structure. We believe that our data has further implications in how we investigate gene expression. We show the power of employing sub-cellular fractionation when analysing genome-wide effects for known transcriptional modulators such as GCs, as well as a tool to demonstrate the extent of the effect of RBPs on gene expression modulation beyond total RNA levels.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 4
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Differential regulation of TCR-induced ZFP36 and ZFP36L1 expression by cyclosporin A in CD8+ T cells
Marian Jones Evans, Twm J. Mitchell, … Martin Turner·bioRxiv·Sep 24, 2025
- BRG1 defines a genomic subset of inflammatory genes transcriptionally controlled by the glucocorticoid receptor
Aikaterini Mechtidou, Franziska Greulich, … N. Henriette Uhlenhaut·bioRxiv·Dec 13, 2021
- Glucocorticoids Mediate Transcriptome-wide Alternative Polyadenylation: Mechanisms and Functional Implications
Thanh Thanh L. Nguyen, Duan Liu, … Richard M. Weinshilboum·bioRxiv·Mar 30, 2022
- Regulation of IFNgamma production by ZFP36L2 in T cells is context-dependent
Nordin D. Zandhuis, Aurélie Guislain, … Monika C. Wolkers·European Journal of ImmunologyPeer-reviewed·Jul 9, 2024
- Expression and role of the RNA-binding protein, ZFP36L1, in mouse T follicular helper cell differentiation and function
Helena A Carslaw, Sam Woolliscroft, … Louise M. C. Webb·European Journal of ImmunologyPeer-reviewed·Aug 1, 2026
- Glucocorticoids regulate the human non-coding genome
Thai H. Tran, Robert Ernest Kwiat, … Luis Miguel Franco·bioRxiv·Dec 18, 2025